Principal Investigators

    St. George-Hyslop, Peter H


    University of Toronto

    Contact information of lead PI



    Title of project or programme

    Mutational and Functional Analysis of Genes Identified by GWAS Studies of Alzheimer's Disease

    Source of funding information


    Total sum awarded (Euro)

    € 957,601

    Start date of award


    Total duration of award in years


    The project/programme is most relevant to:

    Neurodegenerative disease in general


    aging| genetics| neurodegeneration| neuroscience

    Research Abstract

    Lay Summary

    Alzheimer disease (AD) is an incurable neurodegenerative disorder which, as the 4th leading cause of death in adults, is a growing unmet medical need worldwide. Epidemiological studies have identified age and family history as principal risk factors, with genetic factors contributing ~40% of this risk. Half of the genetic risk is attributable to variants in APP, PS1, PS2 or APOE. We have shown that mutations in these genes cause AD by inducing accumulation of Abeta – a neurotoxic aggregation-prone proteolytic fragment of APP. Although the accumulation of Abeta is a widely accepted pathophysiological hallmark of AD, it does not explain several other features of AD (e.g. changes in lipid metabolism, defective autophagy, and progressive spreading of pathology across the brain). To identify other genes potentially involved in these unexplained aspects of AD, we have used a hypothesis-free GWAS approach. This has revealed that AD is associated with SNPs in 9 loci. The current program will focus on 4 of these loci because analysis of their genomic architecture reveals that: i) they each contain only a single gene (making them TRACTABLE GENETIC TARGETS); and ii) these genes had NOT PREVIOUSLY BEEN PREDICTED to play a causal role in AD. Significantly, we have also shown that these genes do not affect Abeta production (indicating that they constitute PROMISING LEADS INTO NOVEL ASPECTS OF AD BIOLOGY). We will identify: a) the disease-causing variants; b) the molecular effects of these variants; and c) the pathways within which these genes work to cause AD. This experiment is TRACTABLE BECAUSE WE HAVE ASSEMBLED NOVEL, CUTTING-EDGE biophysical, molecular, cellular and animal model tools. We will use these tools to assess the impact of these genes on currently unexplained features of AD. The discovery of AD-causing variants and understanding their role in AD will have MAJOR TRANSLATIONAL IMPACT by providing the previously unavailable basis for novel diagnostics and treatments.

    Further information available at:

Types: N/A
Member States: Canada
Diseases: Neurodegenerative disease in general
Years: 2016
Database Categories: N/A
Database Tags: N/A

Export as PDF